Blood Platelet Market Outlook Report 2025-2030: Increased Use of Donated Blood Platelets in Regenerative Medicine and Biotechnology
Blood Platelet Market
Dublin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The "Blood Platelet Market" report has been added to ResearchAndMarkets.com's offering.The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.
Some key organizations in the blood platelet market are the American National Red Cross, Vitalant, Canadian Blood Services, NHS Blood and Transplant and the Red Cross Society of China. These leading organizations run extensive platelet collection, testing and distribution networks. They ensure timely access to safe, high-quality blood products in the nations where they are located. Their commitment to product innovation, donor outreach and regulatory compliance is crucial to improving the efficiency and reliability of the blood platelets supplied to the healthcare industry.Report ScopeThe report provides an overview of the global blood platelet market and analyzes market trends. It includes global revenue ($ million) for base year 2024, estimates for 2025 and a forecast period through 2030. The market is segmented based on platelet type, application, end user and region. The regions covered in this study include North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, focusing on major countries in these regions.The report examines the significant trends and challenges that affect the market and blood donation landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.The report provides an in-depth analysis of the global blood platelets market, with a comprehensive evaluation of the value chain from blood platelets collection to end-use applications. The scope encompasses the activities of blood collection organizations, which are responsible for the voluntary collection of blood donations in each country. These organizations play a critical role in separating, processing and storing platelets from donated blood and ensuring their timely and safe distribution to various healthcare settings.The market analysis covers the distribution of collected blood platelets to various end users, including hospitals, clinics, ambulatory surgical centers, cancer treatment centers, blood banks and transfusion centers. These facilities use blood platelets for multiple clinical and therapeutic purposes.The report also examines the operational models of independent and government-funded organizations while also analyzing regulatory frameworks related to platelet donation, safety protocols and distribution standards across the market.The report concludes with an analysis of the competitive landscape, providing a list of key organizations in the global blood platelet market. It also includes a dedicated section of company profiles that outlines details about leading market enterprises.The report includes:
45 data tables and 53 additional tables
Overview and analysis of the global market for blood platelets, also known as thrombocytes
Analyses of global market trends, with revenue data for 2022-2024, estimates for 2025, and projected CAGRs through 2030
Estimates of the size and revenue prospects for the global blood platelet market, along with a market share analysis by platelet type, application, end-user, and region
Facts and figures pertaining to market dynamics, opportunities and deterrents, technological advances, government policies and regulations and the impacts of macroeconomic variables
Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
An assessment of the current market environment, innovation and prospects, emerging technologies, new developments, and products in the pipeline
Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings and consumer attitudes
Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
Profiles of the leading companies, including American National Red Cross, Vitalant, Canadian Blood Services, NHS Blood and Transplant, and Red Cross Society of China
Key Attributes:
Report Attribute
Details
No. of Pages
136
Forecast Period
2025 - 2030
Estimated Market Value (USD) in 2025
$3.2 Billion
Forecasted Market Value (USD) by 2030
$4 Billion
Compound Annual Growth Rate
4.6%
Regions Covered
Global
Key Topics Covered: Chapter 1 Executive Summary
Market Outlook
Scope of the Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Chapter 2 Market Overview
Key Statistics About Blood Donations
Blood Types Suitable for Platelet Donations
Platelet Donation Process
Porter's Five Forces Analysis
Macroeconomic Factor Analysis
Economic Growth and Healthcare Spending
An Aging Population Worldwide
Government Regulations and Health Policies
Global Disease Burden
Rising Inflation and Cost of Blood Donation Services
Impact of Ongoing Tariffs Imposed by the U.S. on the Blood Platelet Market
Chapter 3 Market Dynamics
Market Drivers
Increased Number of Surgical Procedures
Better Awareness of the Importance of Blood Donations
Rising Government Initiatives
Prevalence of Chronic Blood-Related Disorders
Market Restraints
Elevated Risk of Infection in Platelet Transfusion Procedures
High Cost of Platelet Transfusions
Challenges in Blood Platelet Supply Chain and Logistics
Shortage of Blood Donors
Market Opportunities
Increased Use of Donated Blood Platelets in Regenerative Medicine and Biotechnology
Demand from Emerging Markets and Expanding Healthcare Infrastructure
Chapter 4 Regulatory Landscape
Regulatory Insights into the Blood Platelet Market
Chapter 5 Emerging Technologies
Emerging Technologies
Advances in Pathogen Reduction Techniques for Platelet Collection
Developments in Platelet Storage Systems
Integration of AI and Automation in Blood Collection and Processing
Chapter 6 Market Segmentation Analysis
Market Breakdown by Platelet Type
Apheresis-Derived Platelets
Whole Blood-Derived Platelets
Market Breakdown by Application
Cancer Treatment
Surgical Procedures
Chronic Disease Treatment
Traumatic Injury
Thrombocytopenia (Non-Cancer Related)
Platelet Function Disorder
Market Breakdown by End-user
Hospitals and Clinics
Ambulatory Surgical Centers
Blood Banks and Transfusion Centers
Research Laboratories
Cancer Treatment Centers
Others
Market Breakdown by Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
List of Leading Organizations Across the Globe
Key Developments and Strategies
Partnerships and Collaborations
Business and Service Expansions
Technological Developments
Regulatory and Legal Developments
Chapter 8 Environmental, Social and Governance (ESG) Perspective
Introduction to ESG
Sustainability in the Blood Platelet Market
Concluding Remarks
Company Profiles
AABB - Association for the Advancement of Blood & Biotherapies
America's Blood Centers
Australian Red Cross Lifeblood
Belgian Red Cross-Flanders
Blood Bank of Alaska
Blood Centers of America
Canadian Blood Services
European Blood Alliance
Finnish Red Cross Blood Service
Indian Red Cross Society
Japanese Red Cross Society
Oneblood
Sanbs
The American National Red Cross
Vitalant
For more information about this report visit https://www.researchandmarkets.com/r/lz704u
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Blood Platelet Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
How to get free Burger King Whoppers for 6 days straight
Burger King and Walmart+ lovers to the front. The companies are offering a deal that'll give customers a free Whopper with a $1 purchase for six days straight. The deal is only available for shoppers who are members of both Walmart+ and Burger King Royal Perks programs, a Burger King representative told USA TODAY via email. The deal will run from Tuesday, Aug. 5, to Monday, Aug. 11. The special was announced to celebrate the one-year anniversary of Walmart and Burger King's first-ever joint promotion, launched last summer. Last year's deal gave Walmart+ members 25% off any Burger King digital order every day, as well as a free Whopper every three months starting in September 2024. Here's what to know to get the deal: Read more: Walmart+ members get 25% off Burger King, free Whoppers in new partnership How can I get my free Whopper this week? Guests can take advantage of the deal by linking their Burger King Royal Perks and Walmart+ accounts. To link your accounts: Make sure the Burger King app is downloaded on your device. Download the Walmart app and sign in. Or, log in at Go to "Account." Select "Walmart+ membership." Find the Burger King Savings benefit and select "Get started." The Burger King app should open automatically. Select the "Link accounts" button. Once customers have linked their Walmart+ and Burger King accounts, they can redeem the offer by: ordering in-store using their 6-digit code, opening the Burger King app, going to the 'Offers' tab and activating the offer, and logging in at to place an order. Did someone say diner? Elon Musk fans flock to new Tesla Diner Are there any restrictions? The deal is not available during breakfast hours except at select locations, and customers can only get one free Whopper per account each day, Burger King said. The offer cannot be used with delivery orders. More on Walmart+ and Burger King Royal Perks Walmart+ is Walmart's delivery program that starts at $12.95 a month or $98 annually. The program has student and government assistance eligibility, per the company's website. Royal Parks is Burger King's free rewards program that allows customers to earn points, or crowns, for every $1 spent on eligible transactions. Customers can then cash in the crowns for free menu items. Saleen Martin is a reporter on USA TODAY's NOW team. She is from Norfolk, Virginia – the 757. Email her at sdmartin@ This article originally appeared on USA TODAY: Got Walmart+ and Burger King Royal Perks? Get a free Whopper.
Yahoo
21 minutes ago
- Yahoo
Constellation Brands, Inc. (STZ): A Bull Case Theory
We came across a bullish thesis on Constellation Brands, Inc. on Valueinvesting subreddit by raytoei. In this article, we will summarize the bulls' thesis on STZ. Constellation Brands, Inc.'s share was trading at $175.83 as of July 29th. STZ's trailing and forward P/E were 18.50 and 13.76 respectively according to Yahoo Finance. A winemaker examining a glass of red wine from a barrel in a cellar. Constellation Brands (STZ), trading at $162.68, appears undervalued relative to its historical and potential earnings growth. The company generates $10 billion in revenue, delivers a 2.49% dividend yield, and boasts strong normalized returns—10.51% ROA, 29.45% ROE, and 13.51% ROIC. Despite lumpy performance, normalized EPS has grown from $5.43 in FY2016 to an estimated $13.69 in FY2025, implying a ~12% one-year growth, ~2.9% three-year CAGR, and ~4.2% five-year CAGR, with smoothed long-term growth closer to 8% annually. However, the market appears to price in only 1.09% perpetual growth based on a conservative valuation framework using a 9% discount rate and FY2026 midpoint EPS of $12.75. This is starkly below management guidance, which suggests mid- to high-single-digit EPS growth over the next two years. Analyst projections similarly point to ~7% growth, aligning more with historical performance than with market-implied pessimism. The muted market expectations may stem from overhangs such as GLP-1 obesity drugs, shifting Gen Z preferences, cannabis disruption, tariff concerns, and post-COVID consumption normalization. Yet, these pressures are likely temporary. Constellation retains strong fundamentals and a resilient portfolio, with upside potential if sentiment corrects. Notably, management's April 2024 outlook anticipates FY27 growth in the mid- to high-single digits, and FY28 growth in the low- to mid-single digits. Upcoming Q1 results may also provide clarity on tariffs, impacting peers like Diageo and Brown-Forman. Overall, the current valuation reflects an overly cautious stance, offering a contrarian opportunity for long-term investors willing to bet on normalization and reacceleration in growth.. Previously we covered a bullish thesis on Constellation Brands, Inc. by RepresentativeAd4940 in March 2025, which highlighted brand strength, valuation adjusted for impairments, and steady cash flow. The company's stock price has remained flat since our coverage. This is because the thesis hasn't yet played out due to persistent macro concerns. Raytoei shares an identical view but emphasizes valuation mispricing based on conservative growth assumptions. Constellation Brands, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 44 hedge fund portfolios held STZ at the end of the first quarter which was 51 in the previous quarter. While we acknowledge the potential of STZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None.
Yahoo
21 minutes ago
- Yahoo
Stock market today: Dow jumps 500 points, S&P 500, Nasdaq rally in bounce back from Friday sell-off
US stocks rebounded sharply Monday, recovering from last week's sell-off sparked by disappointing labor data and continuing trade uncertainty. The benchmark S&P 500 (^GSPC) climbed 1.3%, while the blue-chip Dow Jones Industrial Average (^DJI) rose 1.2% or more than 500 points. The tech-heavy Nasdaq Composite (^IXIC) led the gains, rising about 1.8%. The moves follow a sharp pullback on Wall Street on Friday. All three major indexes posted their worst weekly declines in months, ending a run of positive market moves. The declines were exacerbated Friday after July's jobs report came in weaker than expected, and previous months' tallies were revised sharply lower, flipping the narrative on the labor market's strength. It led President Trump to lash out at the Bureau of Labor Statistics (BLS), which publishes the monthly jobs report, and fire its commissioner. Trump suggested he would nominate a new head for the agency in the coming days. Trump's battle with the Fed and Chair Jerome Powell has also remained in focus. Traders tempered expectations around interest rate policy following the bank's decision last week to leave rates unchanged for a fifth consecutive meeting. But after the weak jobs data, almost 90% of bets are on a cut in September. At the same time, investors are examining the fallout from Trump's implementation of tariffs. The updated tariffs set to come into full effect this week range from 10% to 41% on a wide range of trading partners and raise concerns about rising costs amid broader inflationary pressures. On Monday, Trump said he would be "substantially raising" tariffs on India as he presses to stop purchasing Russian oil, effectively accusing the nation of subsidizing Russia's war in Ukraine. Meanwhile, Tesla (TSLA) stock edged higher after reports emerged that the company had granted CEO Elon Musk 96 million shares worth about $29 billion. Read more: The latest on Trump's tariffs Earnings season continues to roll on with a busy week of corporate releases. Over 100 S&P 500 companies are set to report, with spotlights on Palantir (PLTR), Eli Lilly (LLY), and Disney (DIS). Palantir is set to report second quarter earnings after announcing $10 billion US Army deal Yahoo Finance's Laura Bratton reports: Read more here. Rolex, luxury watchmakers brace for Trump's tariffs on Swiss imports Yahoo Finance's Pras Subramanian reports: Read more here. Trump set to announce replacement for Fed governor Kugler this week. Is this a tryout for the Fed Chair? Yahoo Finance's Jennifer Schonberger reports: Read more here. Figma shares sink 20% following last week's blockbuster IPO Figma (FIG) stock dropped more than 20% on Monday following the company's strong public debut last week. Shares of the design software company sank after gaining more than 5% on Friday and jumping over 250% during Thursday's blockbuster IPO. Coinbase stock hit with analyst downgrade citing 'limited support' for current valuation Coinbase (COIN) stock was downgraded by analysts at Compass Point, who questioned whether the crypto platform's valuation was sustainable. The analysts changed Coinbase's rating to Sell from Neutral and lowered its price target to $248 from $330 per share. The new price target represents a 21% decline from Friday's close. "While we remain constructive on the current crypto cycle, we expect a choppy 3Q alongside weak August/September seasonality and waning retail interest in crypto treasury stocks," Compass Point analyst Ed Engel wrote on Sunday night. "As such, we see limited support for COIN's valuation if crypto markets sell off further," he noted. Read more here. American Eagle stock rises 16% after Trump weighs in on viral Sydney Sweeney ad Yahoo Finance's Jake Conley reports: Read more here. Amazon's slowing cloud growth could continue to drag on its stock Yahoo Finance's Francisco Velasquez reports: Read more here. Tariffs not expected to cause recession or end bull market, says UBS As President Trump's tariff policy pans out, UBS strategists signal it won't cause a recession or spell the end of a bull market. 'Our base case remains that US tariffs will eventually settle around 15%," Ulrike Hoffmann-Burchardi, UBS Global Wealth Management's chief investment officer for Americas and global head of equities, wrote in a note on Monday morning. "While this would be the highest since the 1930s, and six times higher than when Trump returned to office, we do not expect it to cause a recession or end the equity bull market." In recent days, Trump has unleashed a flurry of trade deals, including a 90-day reprieve on goods imported from Mexico and 15% tariffs on EU goods. On Friday, Trump signed an order to hike tariffs on Canada to 35%, while he kept a baseline minimum rate of 10% across all US is set to implement duties this week. Trump says he will 'substantially' raise tariffs on India President Trump said on Monday he will "substantially" raise tariffs on India. Stocks still remained in rally mode following Friday's sell-off. "India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump wrote on Monday morning. "They don't care how many people in Ukraine are being killed by the Russian War Machine. Because of this, I will be substantially raising the Tariff paid by India to the USA," he added. President Trump's sweeping tariffs are set to come into full effect later this week. Last Wednesday, Trump announced a 25% tariff on goods from India, plus an additional import tax because of the country's purchasing of Russian oil. Tesla shares jump 3% as board approves $30 billion alternative pay deal for Musk Tesla's (TSLA) shares jumped 3% on Monday after the EV maker's board approved a $30 billion alternative compensation plan for its billionaire CEO, Elon Musk. As Yahoo Finance's Alexis Keenan reports: Read more here. Stocks open higher following market sell-off US stocks opened higher on Monday, rebounding from a sharp sell-off spurred by disappointing labor data and tariff uncertainty. The S&P 500 (^GSPC) climbed 0.6% on Monday, while the tech-heavy Nasdaq Composite (^IXIC) rose 0.9%. The Dow Jones Industrial Average (^DJI) moved up 0.5%. Markets are coming off a Friday sell-off sparked by tariffs on dozens of countries that start on Aug. 7 and monthly jobs revisions to the downside that implied a labor market slowdown is underway. Trending tickers in premarket trading: Opendoor, Palantir, Tesla, Joby, Tyson Here's a look at what's trending in markets ahead of the opening bell: Opendoor (OPEN) stock popped 16% ahead of second quarter results on Monday morning. As my colleague Jake Conley has detailed, the stock has seen a resurgence in investor interest, powered by a bull case by EMJ Capital and speculative bets posted on Reddit forums. Palantir (PLTR) stock rose 2%. On Friday, the company announced it snagged a contract with the US Army that combines over 75 agreements into one package deal worth $10 billion over the next decade. The software and AI data company will report earnings after the bell on Monday. Tesla (TSLA) shares added more than 2% after the company approved a new pay package worth $29 billion for CEO Elon Musk amid an intense court battle in Delaware. The pay package is designed to boost Musk's voting power over time, which shareholders say is key to keeping him focused on the company and its mission, the special committee said in the filing. Joby (JOBY) shares climbed 5% premarket after the electric air taxi developer said it would acquire Blade Air Mobility's helicopter rideshare business for as much as $125 million. The deal would give Joby access to a network of air terminals in key areas like New York City. Blade Air (BLDE) stock rocketed nearly 30% higher on the news. Tyson Foods (TSN) stock increased 4% after the company reported fiscal third quarter results that beat expectations. The company raised its annual revenue forecast and said it expects resilient demand for chicken to offset weakness in the beef segment as high cattle prices weigh on profits. Check out more trending tickers here. Wayfair stock surges after online furniture retailer swings to a profit Wayfair (W) stock shot up 10% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "We are optimistic that sales growth, along with management's commitment to controlling expenses/investments, may create a longer-term positive inflection in earnings revisions, on top of what we view as an attractive valuation," JPMorgan's Christopher Horvers wrote in a note ahead of earnings. "Further, over the next three to five years, [Wayfair] should outgrow the category given the longer-term shift toward online retailing and its advantaged assortment/ supply chain as the largest scaled online specialty player in the industry." Read more live coverage of corporate earnings here. Good morning. Here's what's happening today. Economic data: Factory orders (June) Earnings: Hims & Hers (HIMS), Palantir (PLTR), Tyson (TSN), Wayfair (W) Here are some of the biggest stories you may have missed over the weekend and early this morning: Job market worries in focus as earnings season rolls on Tesla approves near-$30B stock award for Musk US says rare earth talks with China 'halfway there' Trump to name new Fed governor, jobs data head in coming days Boeing defense union strikes for first time since 1996 Morgan Stanley's Wilson: Buy stocks dip on earnings strength Citi's gold bears turn bullish on US growth, inflation concerns Joby to acquire Blade Air's passenger business for $125M Swiss stocks decline on US tariffs, push for lower drug prices Oil slides as traders assess OPEC+ hike and Russian risks Oil eased on Monday as investors digested OPEC+'s latest supply increase, helping to counter a threat from Washington to move against Russian oil flows. Bloomberg News reports: Read more here. Morgan Stanley's Wilson: Buy stocks dip on earnings strength Morgan Stanley's strategist Michael Wilson said on Monday that investors should buy into bthe selloff in US stocks because of the robust earnings outlook for the coming year. Bloomberg reports: Read more here. Citi's gold bears turn bullish on US growth, inflation concerns Citigroup Inc (C) have turned from bearish to bullish on its gold (GC=F) forecast, with analysts now predicting bullion will rally to a record high in the near term due to a worsening US economy and inflation-boosting tariffs. Bloomberg News reports: Read more here. Goldman with a sobering view on the consumer Goldman Sachs out this morning with a subdued outlook on the US consumer following Friday's lackluster jobs report. Good read on the consumer from the WSJ today, mirrors what Procter & Gamble's (PG) CEO told me on earnings day. Goldman's chief economist Jan Hatzius: "We expect the weakness in consumer spending to continue in the second half of the year and forecast 0.8% real spending growth in 2025H2. Our view is underpinned by the expectation of a sharp slowdown in real income growth from its elevated pace in 2025H1. Income growth will be hit in Q3 by the phasing out of the one-off 2025H1 government transfer payments and in Q4 by the Medicaid and SNAP benefit cuts included in the new fiscal bill, which will take effect in 2025Q4 and affect lower-income households in particular. We also see higher tariff-driven inflation to impose a drag on real income growth in the second half of the year. Finally, we expect weak job growth due to lower immigration, cuts in government and healthcare hiring, and a tariff-related decline in activity. We expect declines in both business and residential investment in the second half of the year." Swiss stocks decline on US tariffs, push for lower drug prices Swiss stocks took a hit on Monday as the market reopened after a holiday. Worries about the impact from President Trump's 39% export tariffs and a push for drugmakers to lower prices have caused tension in the market. Bloomberg News reports: Read more here. Gold steady with weak job data bolstering the precious metal Gold (GC=F) held gains after a two month run of positivity as weak jobs data gave another reason to look towards haven assets. Bloomberg reports: Read more here. Palantir is set to report second quarter earnings after announcing $10 billion US Army deal Yahoo Finance's Laura Bratton reports: Read more here. Yahoo Finance's Laura Bratton reports: Read more here. Rolex, luxury watchmakers brace for Trump's tariffs on Swiss imports Yahoo Finance's Pras Subramanian reports: Read more here. Yahoo Finance's Pras Subramanian reports: Read more here. Trump set to announce replacement for Fed governor Kugler this week. Is this a tryout for the Fed Chair? Yahoo Finance's Jennifer Schonberger reports: Read more here. Yahoo Finance's Jennifer Schonberger reports: Read more here. Figma shares sink 20% following last week's blockbuster IPO Figma (FIG) stock dropped more than 20% on Monday following the company's strong public debut last week. Shares of the design software company sank after gaining more than 5% on Friday and jumping over 250% during Thursday's blockbuster IPO. Figma (FIG) stock dropped more than 20% on Monday following the company's strong public debut last week. Shares of the design software company sank after gaining more than 5% on Friday and jumping over 250% during Thursday's blockbuster IPO. Coinbase stock hit with analyst downgrade citing 'limited support' for current valuation Coinbase (COIN) stock was downgraded by analysts at Compass Point, who questioned whether the crypto platform's valuation was sustainable. The analysts changed Coinbase's rating to Sell from Neutral and lowered its price target to $248 from $330 per share. The new price target represents a 21% decline from Friday's close. "While we remain constructive on the current crypto cycle, we expect a choppy 3Q alongside weak August/September seasonality and waning retail interest in crypto treasury stocks," Compass Point analyst Ed Engel wrote on Sunday night. "As such, we see limited support for COIN's valuation if crypto markets sell off further," he noted. Read more here. Coinbase (COIN) stock was downgraded by analysts at Compass Point, who questioned whether the crypto platform's valuation was sustainable. The analysts changed Coinbase's rating to Sell from Neutral and lowered its price target to $248 from $330 per share. The new price target represents a 21% decline from Friday's close. "While we remain constructive on the current crypto cycle, we expect a choppy 3Q alongside weak August/September seasonality and waning retail interest in crypto treasury stocks," Compass Point analyst Ed Engel wrote on Sunday night. "As such, we see limited support for COIN's valuation if crypto markets sell off further," he noted. Read more here. American Eagle stock rises 16% after Trump weighs in on viral Sydney Sweeney ad Yahoo Finance's Jake Conley reports: Read more here. Yahoo Finance's Jake Conley reports: Read more here. Amazon's slowing cloud growth could continue to drag on its stock Yahoo Finance's Francisco Velasquez reports: Read more here. Yahoo Finance's Francisco Velasquez reports: Read more here. Tariffs not expected to cause recession or end bull market, says UBS As President Trump's tariff policy pans out, UBS strategists signal it won't cause a recession or spell the end of a bull market. 'Our base case remains that US tariffs will eventually settle around 15%," Ulrike Hoffmann-Burchardi, UBS Global Wealth Management's chief investment officer for Americas and global head of equities, wrote in a note on Monday morning. "While this would be the highest since the 1930s, and six times higher than when Trump returned to office, we do not expect it to cause a recession or end the equity bull market." In recent days, Trump has unleashed a flurry of trade deals, including a 90-day reprieve on goods imported from Mexico and 15% tariffs on EU goods. On Friday, Trump signed an order to hike tariffs on Canada to 35%, while he kept a baseline minimum rate of 10% across all US is set to implement duties this week. As President Trump's tariff policy pans out, UBS strategists signal it won't cause a recession or spell the end of a bull market. 'Our base case remains that US tariffs will eventually settle around 15%," Ulrike Hoffmann-Burchardi, UBS Global Wealth Management's chief investment officer for Americas and global head of equities, wrote in a note on Monday morning. "While this would be the highest since the 1930s, and six times higher than when Trump returned to office, we do not expect it to cause a recession or end the equity bull market." In recent days, Trump has unleashed a flurry of trade deals, including a 90-day reprieve on goods imported from Mexico and 15% tariffs on EU goods. On Friday, Trump signed an order to hike tariffs on Canada to 35%, while he kept a baseline minimum rate of 10% across all US is set to implement duties this week. Trump says he will 'substantially' raise tariffs on India President Trump said on Monday he will "substantially" raise tariffs on India. Stocks still remained in rally mode following Friday's sell-off. "India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump wrote on Monday morning. "They don't care how many people in Ukraine are being killed by the Russian War Machine. Because of this, I will be substantially raising the Tariff paid by India to the USA," he added. President Trump's sweeping tariffs are set to come into full effect later this week. Last Wednesday, Trump announced a 25% tariff on goods from India, plus an additional import tax because of the country's purchasing of Russian oil. President Trump said on Monday he will "substantially" raise tariffs on India. Stocks still remained in rally mode following Friday's sell-off. "India is not only buying massive amounts of Russian Oil, they are then, for much of the Oil purchased, selling it on the Open Market for big profits," Trump wrote on Monday morning. "They don't care how many people in Ukraine are being killed by the Russian War Machine. Because of this, I will be substantially raising the Tariff paid by India to the USA," he added. President Trump's sweeping tariffs are set to come into full effect later this week. Last Wednesday, Trump announced a 25% tariff on goods from India, plus an additional import tax because of the country's purchasing of Russian oil. Tesla shares jump 3% as board approves $30 billion alternative pay deal for Musk Tesla's (TSLA) shares jumped 3% on Monday after the EV maker's board approved a $30 billion alternative compensation plan for its billionaire CEO, Elon Musk. As Yahoo Finance's Alexis Keenan reports: Read more here. Tesla's (TSLA) shares jumped 3% on Monday after the EV maker's board approved a $30 billion alternative compensation plan for its billionaire CEO, Elon Musk. As Yahoo Finance's Alexis Keenan reports: Read more here. Stocks open higher following market sell-off US stocks opened higher on Monday, rebounding from a sharp sell-off spurred by disappointing labor data and tariff uncertainty. The S&P 500 (^GSPC) climbed 0.6% on Monday, while the tech-heavy Nasdaq Composite (^IXIC) rose 0.9%. The Dow Jones Industrial Average (^DJI) moved up 0.5%. Markets are coming off a Friday sell-off sparked by tariffs on dozens of countries that start on Aug. 7 and monthly jobs revisions to the downside that implied a labor market slowdown is underway. US stocks opened higher on Monday, rebounding from a sharp sell-off spurred by disappointing labor data and tariff uncertainty. The S&P 500 (^GSPC) climbed 0.6% on Monday, while the tech-heavy Nasdaq Composite (^IXIC) rose 0.9%. The Dow Jones Industrial Average (^DJI) moved up 0.5%. Markets are coming off a Friday sell-off sparked by tariffs on dozens of countries that start on Aug. 7 and monthly jobs revisions to the downside that implied a labor market slowdown is underway. Trending tickers in premarket trading: Opendoor, Palantir, Tesla, Joby, Tyson Here's a look at what's trending in markets ahead of the opening bell: Opendoor (OPEN) stock popped 16% ahead of second quarter results on Monday morning. As my colleague Jake Conley has detailed, the stock has seen a resurgence in investor interest, powered by a bull case by EMJ Capital and speculative bets posted on Reddit forums. Palantir (PLTR) stock rose 2%. On Friday, the company announced it snagged a contract with the US Army that combines over 75 agreements into one package deal worth $10 billion over the next decade. The software and AI data company will report earnings after the bell on Monday. Tesla (TSLA) shares added more than 2% after the company approved a new pay package worth $29 billion for CEO Elon Musk amid an intense court battle in Delaware. The pay package is designed to boost Musk's voting power over time, which shareholders say is key to keeping him focused on the company and its mission, the special committee said in the filing. Joby (JOBY) shares climbed 5% premarket after the electric air taxi developer said it would acquire Blade Air Mobility's helicopter rideshare business for as much as $125 million. The deal would give Joby access to a network of air terminals in key areas like New York City. Blade Air (BLDE) stock rocketed nearly 30% higher on the news. Tyson Foods (TSN) stock increased 4% after the company reported fiscal third quarter results that beat expectations. The company raised its annual revenue forecast and said it expects resilient demand for chicken to offset weakness in the beef segment as high cattle prices weigh on profits. Check out more trending tickers here. Here's a look at what's trending in markets ahead of the opening bell: Opendoor (OPEN) stock popped 16% ahead of second quarter results on Monday morning. As my colleague Jake Conley has detailed, the stock has seen a resurgence in investor interest, powered by a bull case by EMJ Capital and speculative bets posted on Reddit forums. Palantir (PLTR) stock rose 2%. On Friday, the company announced it snagged a contract with the US Army that combines over 75 agreements into one package deal worth $10 billion over the next decade. The software and AI data company will report earnings after the bell on Monday. Tesla (TSLA) shares added more than 2% after the company approved a new pay package worth $29 billion for CEO Elon Musk amid an intense court battle in Delaware. The pay package is designed to boost Musk's voting power over time, which shareholders say is key to keeping him focused on the company and its mission, the special committee said in the filing. Joby (JOBY) shares climbed 5% premarket after the electric air taxi developer said it would acquire Blade Air Mobility's helicopter rideshare business for as much as $125 million. The deal would give Joby access to a network of air terminals in key areas like New York City. Blade Air (BLDE) stock rocketed nearly 30% higher on the news. Tyson Foods (TSN) stock increased 4% after the company reported fiscal third quarter results that beat expectations. The company raised its annual revenue forecast and said it expects resilient demand for chicken to offset weakness in the beef segment as high cattle prices weigh on profits. Check out more trending tickers here. Wayfair stock surges after online furniture retailer swings to a profit Wayfair (W) stock shot up 10% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "We are optimistic that sales growth, along with management's commitment to controlling expenses/investments, may create a longer-term positive inflection in earnings revisions, on top of what we view as an attractive valuation," JPMorgan's Christopher Horvers wrote in a note ahead of earnings. "Further, over the next three to five years, [Wayfair] should outgrow the category given the longer-term shift toward online retailing and its advantaged assortment/ supply chain as the largest scaled online specialty player in the industry." Read more live coverage of corporate earnings here. Wayfair (W) stock shot up 10% in premarket trading on Monday after the online furniture retailer reported its highest revenue growth and profitability since 2021. Wayfair posted diluted earnings of $0.11 per share, above estimates for a loss of $0.37 per share, according to S&P Global Market Intelligence. Revenue rose 5% to $3.27 billion, beating Wall Street's expectations of $3.12 billion. Net revenue in the US rose 5.3% to $2.9 billion in the quarter, while international net revenue increased 3.1% to $399 million. "We are optimistic that sales growth, along with management's commitment to controlling expenses/investments, may create a longer-term positive inflection in earnings revisions, on top of what we view as an attractive valuation," JPMorgan's Christopher Horvers wrote in a note ahead of earnings. "Further, over the next three to five years, [Wayfair] should outgrow the category given the longer-term shift toward online retailing and its advantaged assortment/ supply chain as the largest scaled online specialty player in the industry." Read more live coverage of corporate earnings here. Good morning. Here's what's happening today. Economic data: Factory orders (June) Earnings: Hims & Hers (HIMS), Palantir (PLTR), Tyson (TSN), Wayfair (W) Here are some of the biggest stories you may have missed over the weekend and early this morning: Job market worries in focus as earnings season rolls on Tesla approves near-$30B stock award for Musk US says rare earth talks with China 'halfway there' Trump to name new Fed governor, jobs data head in coming days Boeing defense union strikes for first time since 1996 Morgan Stanley's Wilson: Buy stocks dip on earnings strength Citi's gold bears turn bullish on US growth, inflation concerns Joby to acquire Blade Air's passenger business for $125M Swiss stocks decline on US tariffs, push for lower drug prices Economic data: Factory orders (June) Earnings: Hims & Hers (HIMS), Palantir (PLTR), Tyson (TSN), Wayfair (W) Here are some of the biggest stories you may have missed over the weekend and early this morning: Job market worries in focus as earnings season rolls on Tesla approves near-$30B stock award for Musk US says rare earth talks with China 'halfway there' Trump to name new Fed governor, jobs data head in coming days Boeing defense union strikes for first time since 1996 Morgan Stanley's Wilson: Buy stocks dip on earnings strength Citi's gold bears turn bullish on US growth, inflation concerns Joby to acquire Blade Air's passenger business for $125M Swiss stocks decline on US tariffs, push for lower drug prices Oil slides as traders assess OPEC+ hike and Russian risks Oil eased on Monday as investors digested OPEC+'s latest supply increase, helping to counter a threat from Washington to move against Russian oil flows. Bloomberg News reports: Read more here. Oil eased on Monday as investors digested OPEC+'s latest supply increase, helping to counter a threat from Washington to move against Russian oil flows. Bloomberg News reports: Read more here. Morgan Stanley's Wilson: Buy stocks dip on earnings strength Morgan Stanley's strategist Michael Wilson said on Monday that investors should buy into bthe selloff in US stocks because of the robust earnings outlook for the coming year. Bloomberg reports: Read more here. Morgan Stanley's strategist Michael Wilson said on Monday that investors should buy into bthe selloff in US stocks because of the robust earnings outlook for the coming year. Bloomberg reports: Read more here. Citi's gold bears turn bullish on US growth, inflation concerns Citigroup Inc (C) have turned from bearish to bullish on its gold (GC=F) forecast, with analysts now predicting bullion will rally to a record high in the near term due to a worsening US economy and inflation-boosting tariffs. Bloomberg News reports: Read more here. Citigroup Inc (C) have turned from bearish to bullish on its gold (GC=F) forecast, with analysts now predicting bullion will rally to a record high in the near term due to a worsening US economy and inflation-boosting tariffs. Bloomberg News reports: Read more here. Goldman with a sobering view on the consumer Goldman Sachs out this morning with a subdued outlook on the US consumer following Friday's lackluster jobs report. Good read on the consumer from the WSJ today, mirrors what Procter & Gamble's (PG) CEO told me on earnings day. Goldman's chief economist Jan Hatzius: "We expect the weakness in consumer spending to continue in the second half of the year and forecast 0.8% real spending growth in 2025H2. Our view is underpinned by the expectation of a sharp slowdown in real income growth from its elevated pace in 2025H1. Income growth will be hit in Q3 by the phasing out of the one-off 2025H1 government transfer payments and in Q4 by the Medicaid and SNAP benefit cuts included in the new fiscal bill, which will take effect in 2025Q4 and affect lower-income households in particular. We also see higher tariff-driven inflation to impose a drag on real income growth in the second half of the year. Finally, we expect weak job growth due to lower immigration, cuts in government and healthcare hiring, and a tariff-related decline in activity. We expect declines in both business and residential investment in the second half of the year." Goldman Sachs out this morning with a subdued outlook on the US consumer following Friday's lackluster jobs report. Good read on the consumer from the WSJ today, mirrors what Procter & Gamble's (PG) CEO told me on earnings day. Goldman's chief economist Jan Hatzius: "We expect the weakness in consumer spending to continue in the second half of the year and forecast 0.8% real spending growth in 2025H2. Our view is underpinned by the expectation of a sharp slowdown in real income growth from its elevated pace in 2025H1. Income growth will be hit in Q3 by the phasing out of the one-off 2025H1 government transfer payments and in Q4 by the Medicaid and SNAP benefit cuts included in the new fiscal bill, which will take effect in 2025Q4 and affect lower-income households in particular. We also see higher tariff-driven inflation to impose a drag on real income growth in the second half of the year. Finally, we expect weak job growth due to lower immigration, cuts in government and healthcare hiring, and a tariff-related decline in activity. We expect declines in both business and residential investment in the second half of the year." Swiss stocks decline on US tariffs, push for lower drug prices Swiss stocks took a hit on Monday as the market reopened after a holiday. Worries about the impact from President Trump's 39% export tariffs and a push for drugmakers to lower prices have caused tension in the market. Bloomberg News reports: Read more here. Swiss stocks took a hit on Monday as the market reopened after a holiday. Worries about the impact from President Trump's 39% export tariffs and a push for drugmakers to lower prices have caused tension in the market. Bloomberg News reports: Read more here. Gold steady with weak job data bolstering the precious metal Gold (GC=F) held gains after a two month run of positivity as weak jobs data gave another reason to look towards haven assets. Bloomberg reports: Read more here. Gold (GC=F) held gains after a two month run of positivity as weak jobs data gave another reason to look towards haven assets. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
